Impact of Patents on PCR Technology Development
Author Information
Author(s): Joe Fore Jr, Ilse R Wiechers, Robert Cook-Deegan
Primary Institution: Duke University
Hypothesis
How have business practices and intellectual property affected the dissemination of the polymerase chain reaction (PCR) technology?
Conclusion
Despite strict patent protections, PCR has been widely adopted due to effective business practices and licensing strategies.
Supporting Evidence
- PCR has earned approximately $2 billion in royalties for various rights-holders.
- Citation trend analysis shows that PCR's patented status did not prevent its adoption.
- Business partnerships and broad corporate licensing facilitated PCR's dissemination.
Takeaway
This study looks at how a technology called PCR, which helps scientists copy DNA, was shared with many people even though it was patented. Good business choices helped make it available to everyone.
Methodology
The study involved analyzing the history of PCR's development, patenting, and dissemination through case studies and citation trend analysis.
Potential Biases
Potential bias in the interpretation of patent impacts due to the authors' affiliations with the research community.
Limitations
The study may not account for all factors influencing the dissemination of PCR technology.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website